10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0000203077-13-000006`
Period End Date	20130331
Filing Date	20130507
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	stj-20130330.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 40 Cash Flow Statement 60 Comprehensive Income 18

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, less allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$47.00M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$47.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$986.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$966.00M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.05B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $47 million at both March 30, 2013 and December 29, 2012	`AccountsReceivableNetCurrent`	$1.35B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $47 million at both March 30, 2013 and December 29, 2012	`AccountsReceivableNetCurrent`	$1.32B	USD	Point-in-time
Inventories	`InventoryNet`	$610.00M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$602.00M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$220.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$218.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$178.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$240.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	295.65M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.35B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	283.16M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.55B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	283.16M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	295.65M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.69B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.63B	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.20B	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.25B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.43B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.44B	USD	Point-in-time
Goodwill	`Goodwill`	$3.04B	USD	Point-in-time
Goodwill	`Goodwill`	$2.96B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$850.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$804.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$530.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$491.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.16B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.27B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$522.00M	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$530.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$201.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$254.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$71.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$68.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$142.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$139.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$299.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$253.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$482.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$416.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.77B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.83B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.55B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$344.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$323.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$529.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$550.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.18B	USD	Point-in-time
Total liabilities	`Liabilities`	$5.33B	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 283,161,290 and 295,648,327 shares issued and outstanding at March 30, 2013 and December 29, 2012, respectively)	`CommonStockValueOutstanding`	$30.00M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 283,161,290 and 295,648,327 shares issued and outstanding at March 30, 2013 and December 29, 2012, respectively)	`CommonStockValueOutstanding`	$28.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$43.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	-	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.02B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.65B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$21.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$54.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$16.00M	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$4.09B	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$3.74B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$88.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.83B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.09B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$9.16B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$9.27B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.40B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.34B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$358.00M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$359.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$23.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$18.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$381.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$377.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.01B	USD	1 Quarter
Gross profit	`GrossProfit`	$961.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$490.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$468.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$160.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$175.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$25.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$47.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$302.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$308.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-48.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-23.00M	USD	1 Quarter
Earnings before noncontrolling interest and income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$279.00M	USD	1 Quarter
Earnings before noncontrolling interest and income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$260.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$67.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$38.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$212.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$222.00M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$212.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$223.00M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.78	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.67	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.78	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.67	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.23	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.25	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	315.70M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	285.30M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	287.40M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	317.70M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$212.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$222.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$68.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$70.00M	USD	1 Quarter
Amortization of debt premium, net	`AmortizationOfDebtDiscountPremium`	$1.00M	USD	1 Quarter
Amortization of debt premium, net	`AmortizationOfDebtDiscountPremium`	$3.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$19.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$16.00M	USD	1 Quarter
Gain on sale of investment	`AvailableForSaleSecuritiesGrossRealizedGains`	$4.00M	USD	1 Quarter
Gain on sale of investment	`AvailableForSaleSecuritiesGrossRealizedGains`	-	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-10.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-3.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-1.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$34.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$38.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-1.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-7.00M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$11.00M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$67.00M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-46.00M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-96.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$10.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$44.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$183.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$235.00M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$70.00M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$65.00M	USD	1 Quarter
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	-	USD	1 Quarter
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$6.00M	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.00M	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-63.00M	USD	1 Quarter
Exercise of stock options and stock issued, including excess tax benefits	`ProceedsFromStockOptionsExercised`	$51.00M	USD	1 Quarter
Exercise of stock options and stock issued, including excess tax benefits	`ProceedsFromStockOptionsExercised`	$48.00M	USD	1 Quarter
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$609.00M	USD	1 Quarter
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$300.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$68.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$67.00M	USD	1 Quarter
Issuances of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$307.00M	USD	1 Quarter
Issuances of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$211.00M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-14.00M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-333.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-108.00M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$3.00M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-9.00M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$67.00M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-228.00M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$986.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$966.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.05B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$986.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$966.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.05B	USD	Point-in-time
Noncontrolling interest	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	-	USD	1 Quarter
Noncontrolling interest	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	$94.00M	USD	1 Quarter

Comprehensive Income 18 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$212.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$222.00M	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00M	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$2.00M	USD	1 Quarter
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$3.00M	USD	1 Quarter
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Reclassification of realized gain on available-for-sale securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-2.00M	USD	1 Quarter
Reclassification of realized gain on available-for-sale securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	-	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$38.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-27.00M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-25.00M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$38.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$197.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$250.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$198.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$250.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.